ホーム > 鈴木 裕之/ Suzuki, Hiroyuki

鈴木 裕之

ALUMNI 2026年3月現在、筑波大学が主たる所属機関ではありません

Suzuki, Hiroyuki

東北大学 , 大学院医学系研究科 , 准教授
Tohoku University , Graduate School of Medicine , Associate Professor

http://www.md.tsukuba.ac.jp/epatho/

http://www.md.tsukuba.ac.jp/younginit/

シグナル伝達の異常に起因した疾患 を治療する創薬開発に向けた研究
シグナル伝達と疾患リサーチユニット
Research for drug discovery to treat diseases caused by abnormal cellular signaling

2017-05-16

金保 安則 加藤 光保 熊谷 嘉人 高橋 智 渋谷 彰 渋谷 和子 入江 賢児 鈴木 裕之 船越 祐司 新開 泰弘
  1. 1. Design and Evaluation of Eb4Mab-7-mG2a: A Dual-Action Anti-EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy. Tomokazu Ohishi; Hiroyuki Suzuki; Mika K Kaneko; Tomohiro Tanaka (+4 著者) Manabu Kawada
      Cancer science (2025) Semantic Scholar
  2. 2. Antitumor Activity by an Anti-CD44 Variant 9 Monoclonal Antibody in Gastric and Colorectal Cancer Xenograft Models. Mayuki Tawara; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K KanekoYukinari Kato
      International journal of molecular sciences 26: (2025) Semantic Scholar
  3. 3. Development of a novel anti-human glypican 5 monoclonal antibody (G5Mab-1) for multiple applications. Yu Kaneko; Tomohiro Tanaka; Shiori Fujisawa; Guanjie Li (+3 著者) Yukinari Kato
      Biochemistry and biophysics reports 43: 102140 (2025) Semantic Scholar
  4. 4. Development of a specific anti-human EphA3 monoclonal antibody, Ea3Mab-20, for flow cytometry. Hiroyuki Satofuka; Hiroyuki Suzuki; Miu Hirose; Keisuke Shinoda (+3 著者) Yukinari Kato
      Biochemistry and biophysics reports 43: 102130 (2025) Semantic Scholar
  5. 5. Development of an anti-CDH15/M-cadherin monoclonal antibody Ca15Mab-1 for flow cytometry, immunoblotting, and immunohistochemistry. Rena Ubukata; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
      Biochemistry and biophysics reports 43: 102138 (2025) Semantic Scholar
  6. 6. PMab-322: a novel anti-hippopotamus podoplanin monoclonal antibody for multiple applications. Haruto Yamamoto; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
      Biochemistry and biophysics reports 43: 102170 (2025) Semantic Scholar
  7. 7. A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models. Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura; Miyuki Yanaka (+3 著者) Yukinari Kato
      Antibodies (Basel, Switzerland) 14: (2025) Semantic Scholar
  8. 8. Ea8Mab-9: A novel monoclonal antibody against erythropoietin-producing hepatocellular receptor A8 for flow cytometry Tomohiro Tanaka; Haruto Yamamoto; Yu Kaneko; Keisuke Shinoda (+6 著者) Yukinari Kato
      Microbes & Immunity 025060010 (2025) Semantic Scholar
  9. 9. Development of a Novel Anti-human EphA1 Monoclonal Antibody, Ea1Mab-30, for Multiple Applications. Tomohiro Tanaka; Hiroyuki Suzuki; Honoka Taruta; Ayano Saga (+3 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 44: 41 (2025) Semantic Scholar
  10. 10. A novel anti-mouse CXCR1 monoclonal antibody, Cx1Mab-8, demonstrates nanomolar affinity in flow cytometry. Guanjie Li; Hiroyuki Suzuki; Tomohiro Tanaka; Hiroyuki Satofuka (+1 著者) Yukinari Kato
      Biochemistry and biophysics reports 42: 101965 (2025) Semantic Scholar
  11. 11. Development of an anti-human EphA2 monoclonal antibody Ea2Mab-7 for multiple applications Hiroyuki Satofuka; Hiroyuki Suzuki; Tomohiro Tanaka; Guanjie Li (+1 著者) Yukinari Kato
      Biochemistry and Biophysics Reports (2025) Semantic Scholar
  12. 12. Antitumor Activities by a Humanized Cancer-Specific Anti-Podoplanin Monoclonal Antibody humPMab-117 Against Human Tumors. Tomohiro Tanaka; Hiroyuki Suzuki; Tomokazu Ohishi; Manabu Kawada (+1 著者) Yukinari Kato
      Cancer science (2025) Semantic Scholar
  13. 13. Development of a novel anti-erythropoietin-producing hepatocellular receptor B6 monoclonal antibody Eb6Mab-3 for flow cytometry. Tomohiro Tanaka; Yu Kaneko; Haruto Yamamoto; Guanjie Li (+6 著者) Yukinari Kato
      Biochemistry and biophysics reports 41: 101960 (2025) Semantic Scholar
  14. 14. A novel anti-mouse CCR7 monoclonal antibody, C7Mab-7, demonstrates high sensitivity in flow cytometry, western blot, and immunohistochemistry. Hiroyuki Satofuka; Hiroyuki Suzuki; Tomohiro Tanaka; Rena Ubukata (+6 著者) Yukinari Kato
      Biochemistry and biophysics reports 41: 101948 (2025) Semantic Scholar
  15. 15. THG-1/TSC22D4 promotes interleukin-1 signaling through stabilization of TRAF6 in squamous cell carcinoma. Yasuhito Okano; Hiroyuki Suzuki; Yukihide Watanabe; Mohammed Abdelaziz (+14 著者) Mitsuyasu Kato
      Molecular cancer research : MCR (2025) Semantic Scholar
  16. 16. Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts. Mika K Kaneko; Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura (+2 著者) Yukinari Kato
      International journal of molecular sciences 26: (2025) Semantic Scholar
  17. 17. Establishment of a Highly-Sensitive and Specific anti-EphB2 Monoclonal Antibody Eb2Mab-12 for Flow Cytometry Rena Ubukata; Hiroyuki Suzuki; Miu Hirose; Hiroyuki Satofuka (+2 著者) Yukinari Kato
      Microbes & Immunity 5728 (2025)
  18. 18. Establishment of a high-affinity anti-mouse CXCR5 monoclonal antibody for flow cytometry Kenichiro Ishikawa; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K. KanekoYukinari Kato
      Microbes & Immunity 2: 101 (2024) Semantic Scholar
  19. 19. C8Mab-21: A Novel Anti-human CCR8 Monoclonal Antibody for Flow Cytometry Haruto Yamamoto; Yu Kaneko; Tomohiro Tanaka; Guanjie Li (+2 著者) Yukinari Kato
      Microbes & Immunity 2: 126 (2024)
  20. 20. Development of specific anti-mouse atypical chemokine receptor 4 monoclonal antibodies. Miu Hirose; Hiroyuki Suzuki; Rena Ubukata; Tomohiro Tanaka (+1 著者) Yukinari Kato
      Biochemistry and biophysics reports 40: 101824 (2024) Semantic Scholar
1 2 3 … 10
  1. 1. あなたのラボから薬を生み出すアカデミア創薬の実践 : all Japan体制の先端技術支援を利用した創薬の最前線 善光, 龍哉; 辻川, 和丈 (担当:分担執筆, 範囲:CBIS法による高感度抗体の作製)
    羊土社 2024年2月 (ISBN: 9784758104166)
  2. 2. がんゲノム医療時代の分子腫瘍学 鈴木裕之; 後藤のはら; 加藤光保 (担当:分担執筆, 範囲:TGF-β経路)
    文光堂 2022年4月
  3. 3. 炎症メディエーター TGF-β 鈴木,裕之; 青山,知恵; 加藤,光保 (担当:共著)
    日本臨床 2009年5月
  4. 4. TGF-betaシグナル伝達系とがん治療 鈴木裕之; 中条友香; 加藤光保 (担当:監修)
    南山堂 2008年9月
  5. 5. TGF-βシグナル伝達とがん治療 鈴木裕之; 中条友香; 加藤光保 (担当:分担執筆)
    がんの分子標的治療 2008年6月
  6. 6. Negative regulation of the TGF-β family signal pathway by inhibitory Smads and their involvement in cancer and fibrosis. Itoh S; Suzuki H; Itoh F; Miyazono K; Kato M (担当:共著)
    Humana Press Inc. 2008年
  7. 7. IGFBP 鈴木裕之; 加藤光保 (担当:監修)
    サイトカイン・増殖因子用語ライブラリー / 羊土社 2005年3月
  8. 8. TGF-betaシグナルと疾患 鈴木裕之; 宮園浩平 (担当:監修)
    シグナル伝達研究2003 シグナル伝達研究2003 羊土社 2003年1月

 2,918 total views